Nolan Sigal

Nolan Sigal

Private Equity Investor chez
Alerce Investment Management LP
75 ans
Health Technology
Consumer Services
Commercial Services

Profil

Nolan H.
Sigal
was the founder of Tunitas Therapeutics, Inc. (founded in 2007) where he held the titles of President, Chief Executive Officer & Director from 2007 to 2017.
He is currently a Partner at Alerce Investment Management LP since 2017.
Dr. Sigal's former positions include being an Executive Director-Immunology Research at Merck & Co., Inc. from 1983 to 1993, a Director at Clearant, Inc., an Independent Director at Aileron Therapeutics, Inc. from 2019 to 2024, a Senior Vice President at Pharmacopeia LLC from 1993 to 1999, a CSO, EVP-Research & Development at Cytokinetics, Inc., and the President of Trellis Bioscience, Inc. from 2004 to 2007.
He also served as an Assistant Professor at the University of Toronto from 1980 to 1984 and as a Senior Vice President-Research at Pharmacopeia, Inc.Dr. Sigal obtained his undergraduate degree from Princeton University in 1971 and his doctorate degree from the University of Pennsylvania Medical Center in 1977.

Postes actifs de Nolan Sigal

SociétésPosteDébut
Private Equity Investor 01/12/2017

Anciens postes connus de Nolan Sigal

SociétésPosteFin
REIN THERAPEUTICS INC. Directeur/Membre du Conseil 29/02/2024
Fondateur 01/12/2017
Directeur/Membre du Conseil 25/04/2007
President 01/01/2007
Corporate Officer/Principal 01/10/1999
Voir l'expérience en détail de Nolan Sigal

Formation de Nolan Sigal

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

99

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Consumer Services

Finance

  1. Bourse
  2. Insiders
  3. Nolan Sigal